Peru issues regulatory guidelines for medical cannabis
By Espinosa Bellido Abogados

Under the released guidelines, businesses are first required to submit security protocols which detail a specific anti-diversion plan to the Anti-Narcotics Unit of the Ministry of Interior (Dirandro for its Spanish acronym). Upon approval of their security plan, companies can then present a license application for final approval.
In Peru, only registered pharmaceutical establishments who have fulfilled GSP requirements are authorized to participate in wholesale import and commercialization of cannabis products. The country legalized medical cannabis in 2017, although the law did not include guidelines for companies to apply for required licenses.
